Clinical trial
Study of HuCNS-SC Cells in Patients With Infantile or Late Infantile Neuronal…
NCT00337636 · StemCells, Inc., Industry · Completed
Key facts
| NCT number | NCT00337636 |
|---|---|
| Title | Study of HuCNS-SC Cells in Patients With Infantile or Late Infantile Neuronal Ceroid Lipofuscinosis (NCL) |
| Official title | A Phase I Study of the Safety and Preliminary Effectiveness of Human CNS Stem Cells (HuCNS-SC) in Patients With Neuronal Ceroid Lipofuscinosis Caused by Palmitoyl Protein Thioesterase 1 (PPT1) or Tripeptidyl Peptidase 1 (TPP-I) Deficiency |
| Lead sponsor | StemCells, Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neuronal Ceroid Lipofuscinosis |
| Intervention type | Drug, Procedure |
| Interventions | Surgery to implant human CNS stem cells (HuCNS-SC), Medication to suppress the immune system |
| Enrollment | 6 |
| Start date | May 1, 2006 |
| Primary completion | Feb 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Jun 16, 2006 |
| Last update posted | Jan 15, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: